§LongevityResearch protocol
NAD+.
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function[1]. Clinical research has primarily employed intraveno...
Vial Size:
Research Use Only. PeptiJournal supports private research documentation and calculation support. It does not provide medical advice, human-use directions, or claims of safety or effectiveness.
Cited diluent3 mL
Cited protocol example—review and confirm.
Reference syringe capacity
Concentration
166,666.667
mcg/mL
Per event
50 mg
7 events/week
Vials projected
22
16 cited weeks
Calculated volume reference
30.0 units
1mL syringe
NAD+
30.0u(0.300 mL)
Daily
Cited protocol & reconstitution guide
Source-backed reference fields by phase, including any volume fields authored in the cited guide.
Week 1
50 mg
Units / volume30 units (0.30 mL)
Week 2
75 mg
Units / volume45 units (0.45 mL)
Weeks 3–8
100 mg
Units / volume60 units (0.60 mL)
Weeks 9–12
100 mg
Units / volume60 units (0.60 mL)
Weeks 13–16
100 mg
Units / volume60 units (0.60 mL)
| Phase | Daily reference amount | Units / volume |
|---|---|---|
| Week 1 | 50 mg | 30 units (0.30 mL) |
| Week 2 | 75 mg | 45 units (0.45 mL) |
| Weeks 3–8 | 100 mg | 60 units (0.60 mL) |
| Weeks 9–12 | 100 mg | 60 units (0.60 mL) |
| Weeks 13–16 | 100 mg | 60 units (0.60 mL) |
Reconstitution by vial size
Calculated volume for each cited phase and vial variant. The highlighted column matches the selection above.
| Phase | 500 mg 3 mL water | 1000 mg 3 mL water |
|---|---|---|
| Week 1 | 30 u 0.30 mL | 15 u 0.15 mL |
| Week 2 | 45 u 0.45 mL | 22.5 u 0.23 mL |
| Weeks 3–8 | 60 u 0.60 mL | 30 u 0.30 mL |
| Weeks 9–12 | 60 u 0.60 mL | 30 u 0.30 mL |
| Weeks 13–16 | 60 u 0.60 mL | 30 u 0.30 mL |
Cited guide source: View source